June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Six UGI Patterns Distinguish Neonatal Obstructions

A new research-based review outlines clear imaging patterns and diagnostic strategies to help radiologists quickly identify and manage neonatal bowel obstructions—one of the most common surgical emergencies in newborns.

Conexiant

June 24, 2025

AI vs. MDs: Who Navigates the Airways Better?

A new systematic review evaluated 20 studies on artificial intelligence in bronchoscopy and found AI systems often performed as well as or better than human experts in tasks such as airway navigation and lymph node classification.

Conexiant

June 20, 2025

AI Screening Finds More Aneurysms In Breast MRI

An artificial intelligence system significantly increased detection of thoracic aortic aneurysms during routine breast MRI scans, identifying more cases than standard clinical readings.

Conexiant

June 06, 2025

Abbreviated MRI Matches Accuracy, Study Finds

A study involving women with dense breast tissue found that an abbreviated breast MRI protocol was as effective as the full version in detecting cancer—while taking less than half the time to complete.

Conexiant

May 23, 2025

New Inhaled Treprostinil Option Approved

Yutrepia represents an additional therapeutic option within the prostacyclin class for the management of PAH and PH-ILD.

Conexiant

April 25, 2025

FDA Approves Penpulimab-kcqx for NPC

The FDA approved penpulimab-kcqx for first line and previously treated recurrent or metastatic non-keratinizing nasopharyngeal carcinoma.

Conexiant

May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant